Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02688140
Title Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Technische Universität Dresden
Indications

acute promyelocytic leukemia

Therapies

Arsenic trioxide + Idarubicin + Tretinoin

Mercaptopurine + Methotrexate + Tretinoin

Cytarabine + Idarubicin + Tretinoin

Mitoxantrone + Tretinoin

Idarubicin + Tretinoin

Age Groups: adult | senior
Covered Countries ITA | FRA | ESP | DEU


No variant requirements are available.